The pathogenic mutations in genes such as MUTYH, FANCD2, NBN, PALB2, and BRCA1 are associated with hereditary breast and ovarian cancer syndrome, an autosomal dominant disorder typically manifesting around age 30 and above [76]. This evidence concerns the gene BRCA1 and hereditary breast ovarian cancer syndrome.